A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases

Emily J. Erbelding(National Institute of Allergy and Infectious Diseases), Diane J. Post(National Institute of Allergy and Infectious Diseases), Erik J. Stemmy(National Institutes of Health), Paul C. Roberts(National Institute of Allergy and Infectious Diseases), Alison D. Augustine(National Institutes of Health), S E Ferguson(National Institute of Allergy and Infectious Diseases), Catharine I. Paules(National Institute of Allergy and Infectious Diseases), Barney S. Graham(National Institute of Allergy and Infectious Diseases), Anthony S. Fauci(National Institutes of Health)
The Journal of Infectious Diseases
February 21, 2018
10.1093/infdis/jiy103
Cited by 467Open Access
Full Text

Abstract

A priority for the National Institute of Allergy and Infectious Diseases is development of a universal influenza vaccine providing durable protection against multiple influenza strains. NIAID will use this strategic plan as a foundation for future investments in influenza research.

Related Papers

No related papers found

Powered by citation graph analysis